NCT02452762View on ClinicalTrials.gov

Rapid Normalization of Vitamin D in Critically Ill Children: A Phase II Dose Evaluation Randomized Controlled Trial

PHASE2CompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

November 30, 2017

Study Completion Date

January 31, 2018

Conditions
Hypovitaminosis D
Interventions
DRUG

Vitamin D3

DRUG

Placebo

Trial Locations (4)

8036

Medical University of Graz, Graz

N6C 3T6

Division of Critical Care, Department of Pediatrics, Victoria Hospital, London

K1H 8L1

Children's Hospital of Eastern Ontario, Ottawa

Unknown

Hospital Guillermo Grant Benavente, Concepción

All Listed Sponsors
lead

Children's Hospital of Eastern Ontario

OTHER

NCT02452762 - Rapid Normalization of Vitamin D in Critically Ill Children: A Phase II Dose Evaluation Randomized Controlled Trial | Biotech Hunter | Biotech Hunter